HPV Genotyping Kit

A nucleic acid detection kit designed to identify 14 types of high-risk human papillomavirus (HPV) with specific genotyping for HPV types 16 and 18. This test kit enables comprehensive HPV screening and risk stratification for cervical cancer prevention. The kit provides detailed genotyping information for clinical management and patient counseling.

A nucleic acid-based PCR test kit for genotyping of human papillomavirus. Provides comprehensive identification of HPV strains for clinical assessment.

A diagnostic test kit detecting 18 types of human papillomavirus including 14 high-risk types recognized by WHO as causative agents of cervical cancer and 4 medium-risk types associated with cervical cancer, using hybrid capture-chemiluminescence method.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

A qualitative test kit for detecting and genotyping 15 types of human papillomavirus (HPV) DNA in cervical exfoliative cells or urine samples using fluorescent PCR methodology. The kit can identify and differentiate HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 73.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.

Qualitatively detects high-risk human papillomavirus (HPV) DNA in cervical exfoliate cells or urine samples, including types 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82, with specific genotyping identification for types 16 and 18. It uses fluorescent PCR technology and has obtained CE certification.

A comprehensive nucleic acid detection kit capable of identifying 28 different types of human papillomavirus (HPV). This diagnostic test provides broad HPV coverage including both high-risk and low-risk types for comprehensive cervical cancer screening. The kit is designed for clinical laboratory and cervical cancer prevention programs.

A diagnostic test kit for the detection of human papillomavirus (HPV) nucleic acids. The kit detects 18 types of HPV including 14 high-risk types recognized by the WHO that can lead to cervical cancer, as well as 4 medium-risk types identified by authoritative research as potentially related to cervical cancer. It uses hybridization capture and chemiluminescence methodology.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

A diagnostic kit for identification of 14 low-risk HPV types, compatible with Sanity 2.0, Sanity 2.0s, and Sanity 2.1 systems. The kit contains 24 tests per kit and is designed for automated HPV genotyping analysis on the specified instrumentation platforms. Available variants: High Risk HPV Genotyping Kit (Sanity 2.0).

Microarray-based diagnostic test for detection and genotyping of human papillomavirus strains. Manufactured using precision microarray printing technology for reliable clinical detection.